Clofarabine-based conditioning for T-cell replete haploidentical hematopoietic stem cell transplant for relapsed/refractory acute leukemia using peripheral blood stem cell grafts and post-transplantation cyclophosphamide
Main Authors: | Prashant Mehta, Rahul Arora |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Cancer Research, Statistics, and Treatment |
Online Access: | http://www.crstonline.com/article.asp?issn=2590-3233;year=2020;volume=3;issue=3;spage=614;epage=617;aulast=Mehta |
Similar Items
-
Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant
by: Samuel Cytryn, et al.
Published: (2020-04-01) -
Outpatient haploidentical hematopoietic stem cell transplant using post-transplant cyclophosphamide and incidence of hemorrhagic cystitis
by: Cesar Homero Gutiérrez-Aguirre, et al.
Published: (2022-04-01) -
Clofarabine Preconditioning followed by Allogeneic Transplant Using TBI and Post-Transplant Cyclophosphamide for Relapsed Refractory Leukemia
by: Seema Naik, et al.
Published: (2024-01-01) -
Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
by: Razan Mohty, et al.
Published: (2024-12-01) -
Autoimmune Limbic Encephalitis in Patients with Hematologic Malignancies after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide
by: Bu Yeon Heo, et al.
Published: (2023-08-01)